Table 4. FCGR2A rs1801274 allele A and the risk of Kawasaki disease in meta-analysis.
| Study ID | A/G in cases | A/G in controls | Transmitted A | Non-transmitted A | OR (95% CI) |
| Taniuchi (2005) [37] | 108/22 | 885/247 | — | — | 1.37 (0.85–2.21) |
| Biezeveld (2006) [38] | 202/150 | 250/228 | — | — | 1.23 (0.93–1.62) |
| Khor (2011) [22] | 616/260 | 559/333 | — | — | 1.41 (1.16–1.72) |
| Khor (2011) [22] | 200/60 | 728/408 | — | — | 1.87 (1.37–2.55) |
| Khor (2011) [22] | 726/194 | 757/239 | — | — | 1.18 (0.95–1.46) |
| Khor (2011) [22] | 459/351 | 5877/6627 | — | — | 1.47 (1.28–1.70) |
| Khor (2011) [22] | — | — | 314 | 272 | 1.15 (0.98–1.36) |
| Onouchi (2012) [23] | 720/136 | 5406/1352 | — | — | 1.32 (1.09–1.61) |
| Onouchi (2012) [23] | 790/150 | 590/166 | — | — | 1.48 (1.16–1.89) |
| Onouchi (2012) [23] | 482/86 | 910/228 | — | — | 1.40 (1.07–1.84) |
| Ji (2013) [39] | 55/15 | 26/24 | — | — | 3.38 (1.53–7.50) |
| Yan (2013) [36] | 528/188 | 1106/524 | — | — | 1.33 (1.09–1.62) |
| Current study (2013) | 609/239 | 652/330 | — | — | 1.29 (1.06–1.57) |
| Pooled OR | — | — | — | — | 1.35 (1.27–1.44)a |
a
Fixed-effects OR, Q = 17.30, P heterogeneity = 0.139, p<0.001.